Header cover image
  • Investing Ideas
  • /
  • Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

1

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Saniona

Market Cap: SEK 981.2m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, Germany, Denmark, the United Kingdom, and Mexico.

SANION

SEK 7.21

7D

17.2%

1Y

305.5%